The United States of America; as represented by the Secretary; Department of Health and Human Services
发明人:
YOSEPH, Rami,LU, Yong-Chen,CAFRI, Gal,ROSENBERG, Steven A.
申请号：
AU2018378200
公开号：
AU2018378200A1
申请日:
2018.12.03
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Disclosed is an isolated or purified T cell receptor (TCR), wherein the TCR has antigenic specificity for a mutated RAS amino acid sequence presented by a human leukocyte antigen (HLA) Class I molecule. Related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, populations of cells, and pharmaceutical compositions are also provided. Also disclosed are methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.
